Piperacillin therapy for serious bacterial infections
Authors:
- Drew J. WinstonDWDrew J. Winston
- Wendy MurphyWMWendy Murphy
- Lowell S. YoungLYLowell S. Young
- William L. HewittWHWilliam L. Hewitt
- 1 August 1980
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 69 (2) , 255-261
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparative In Vitro Activity of Azlocillin, Ampicillin, Mezlocillin, Piperacillin, and Ticarcillin, Alone and in Combination with an AminoglycosideAntimicrobial Agents and Chemotherapy, 1979
- Susceptibility of Gram-Negative Aerobic Bacilli Resistant to Carbenicillin in a General Hospital to Piperacillin and TicarcillinAntimicrobial Agents and Chemotherapy, 1979
- Comparative Evaluation of Piperacillin in VitroAntimicrobial Agents and Chemotherapy, 1978
- Piperacillin: In Vitro EvaluationAntimicrobial Agents and Chemotherapy, 1978
- In Vitro Studies of Piperacillin, a New Semisynthetic PenicillinAntimicrobial Agents and Chemotherapy, 1978
- Piperacillin, a new penicillin active against many bacteria resistant to other penicillinsAntimicrobial Agents and Chemotherapy, 1978
- In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activityAntimicrobial Agents and Chemotherapy, 1978
- In Vitro and In Vivo Antibacterial Activity of T-1220, a New Semisynthetic PenicillinAntimicrobial Agents and Chemotherapy, 1977
- Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.The Journal of Antibiotics, 1977
- Carbenicillin and HypokalemiaAnnals of Internal Medicine, 1973